443 related articles for article (PubMed ID: 21211831)
1. Clinical importance of "low-grade squamous intraepithelial lesion, cannot exclude high-grade squamous intraepithelial lesion (LSIL-H)" terminology for cervical smears 5-year analysis of the positive predictive value of LSIL-H compared with ASC-H, LSIL, and HSIL in the detection of high-grade cervical lesions with a review of the literature.
Ince U; Aydin O; Peker O
Gynecol Oncol; 2011 Apr; 121(1):152-6. PubMed ID: 21211831
[TBL] [Abstract][Full Text] [Related]
2. The significance of "low-grade squamous intraepithelial lesion, cannot exclude high-grade squamous intraepithelial lesion" as a distinct squamous abnormality category in Papanicolaou tests.
Elsheikh TM; Kirkpatrick JL; Wu HH
Cancer; 2006 Oct; 108(5):277-81. PubMed ID: 16937376
[TBL] [Abstract][Full Text] [Related]
3. Is the low-grade squamous intraepithelial lesion/atypical squamous cells cannot exclude high-grade squamous intraepithelial lesion category associated with cervical intraepithelial neoplasia 2?
Cetiner H; Kır G; Kaygusuz E; Sağlıcan Y; Kabaca C
Acta Cytol; 2013; 57(6):581-4. PubMed ID: 24107612
[TBL] [Abstract][Full Text] [Related]
4. Low-grade squamous intraepithelial lesion, cannot rule out high-grade lesion: Diagnosis, histological outcomes and human papillomavirus results.
Segura SE; Ramos-Rivera G; Hakima L; Suhrland M; Khader S
Cytopathology; 2019 Jan; 30(1):99-104. PubMed ID: 30187975
[TBL] [Abstract][Full Text] [Related]
5. Evidence for increasing usage of low-grade squamous intraepithelial lesion, cannot exclude high-grade squamous intraepithelial lesion (LSIL-H) Pap test interpretations.
Walavalkar V; Tommet D; Fischer AH; Liu Y; Papa DM; Owens CL
Cancer Cytopathol; 2014 Feb; 122(2):123-7. PubMed ID: 23983192
[TBL] [Abstract][Full Text] [Related]
6. Distribution of human papillomavirus types in ThinPrep Papanicolaou tests classified according to the Bethesda 2001 terminology and correlations with patient age and biopsy outcomes.
Evans MF; Adamson CS; Papillo JL; St John TL; Leiman G; Cooper K
Cancer; 2006 Mar; 106(5):1054-64. PubMed ID: 16421920
[TBL] [Abstract][Full Text] [Related]
7. Low-grade squamous intraepithelial lesion/cannot exclude high-grade squamous intraepithelial lesion (LSIL-H) is a unique category of cytologic abnormality associated with distinctive HPV and histopathologic CIN 2+ detection rates.
Barron S; Li Z; Austin RM; Zhao C
Am J Clin Pathol; 2014 Feb; 141(2):239-46. PubMed ID: 24436272
[TBL] [Abstract][Full Text] [Related]
8. The significance of the Papanicolaou smear diagnosis of low-grade squamous intraepithelial lesion cannot exclude high-grade squamous intraepithelial lesion.
Nasser SM; Cibas ES; Crum CP; Faquin WC
Cancer; 2003 Oct; 99(5):272-6. PubMed ID: 14579293
[TBL] [Abstract][Full Text] [Related]
9. Clinical significance of the diagnosis of low-grade squamous intraepithelial lesion, cannot exclude high-grade squamous intraepithelial lesion.
Alsharif M; Kjeldahl K; Curran C; Miller S; Gulbahce HE; Pambuccian SE
Cancer; 2009 Apr; 117(2):92-100. PubMed ID: 19365830
[TBL] [Abstract][Full Text] [Related]
10. Utility of p16 Immunohistochemistry in Evaluating Negative Cervical Biopsies Following High-risk Pap Test Results.
Shain AF; Kwok S; Folkins AK; Kong CS
Am J Surg Pathol; 2018 Jan; 42(1):69-75. PubMed ID: 29112019
[TBL] [Abstract][Full Text] [Related]
11. "Low-grade squamous intraepithelial lesion, cannot exclude high-grade squamous intraepithelial lesion" is a distinct cytologic category: histologic outcomes and HPV prevalence.
Owens CL; Moats DR; Burroughs FH; Gustafson KS
Am J Clin Pathol; 2007 Sep; 128(3):398-403. PubMed ID: 17709313
[TBL] [Abstract][Full Text] [Related]
12. Overall accuracy of cervical cytology and clinicopathological significance of LSIL cells in ASC-H cytology.
Kim SH; Lee JM; Yun HG; Park US; Hwang SU; Pyo JS; Sohn JH
Cytopathology; 2017 Feb; 28(1):16-23. PubMed ID: 27245707
[TBL] [Abstract][Full Text] [Related]
13. The impact of LSIL-H terminology on patient follow-up patterns: a comparison with LSIL and ASC-H.
Thrall MJ; Galfione SK; Smith DA
Diagn Cytopathol; 2013 Nov; 41(11):960-4. PubMed ID: 23554221
[TBL] [Abstract][Full Text] [Related]
14. Comparison of the clinical significance of the Papanicolaou test interpretations LSIL cannot rule out HSIL and ASC-H.
Difurio MJ; Mailhiot T; Sundborg MJ; Nauschuetz KK
Diagn Cytopathol; 2010 May; 38(5):313-7. PubMed ID: 19813258
[TBL] [Abstract][Full Text] [Related]
15. Low-grade pap smears containing occasional high-grade cells as a predictor of high-grade dysplasia.
Power P; Gregoire J; Duggan M; Nation J
J Obstet Gynaecol Can; 2006 Oct; 28(10):884-887. PubMed ID: 17140504
[TBL] [Abstract][Full Text] [Related]
16. [Significance of p16/Ki-67 double immunocytochemical staining in cervical cytology ASCUS, LSIL, and ASC-H].
Wu Y; Zhao J; Hu J; Wu XW; Zhu LR
Zhonghua Fu Chan Ke Za Zhi; 2017 Nov; 52(11):734-739. PubMed ID: 29179267
[No Abstract] [Full Text] [Related]
17. Significance of high-risk human papillomavirus DNA detection in women 50 years and older with squamous cell papanicolaou test abnormalities.
Zhao C; Zhao S; Heider A; Austin RM
Arch Pathol Lab Med; 2010 Aug; 134(8):1130-5. PubMed ID: 20670132
[TBL] [Abstract][Full Text] [Related]
18. The clinical significance of "squamous intraepithelial lesion of indeterminate grade" as a distinct cytologic category.
Wong D; Teschendorf C; Lin GY; Hasteh F
Am J Clin Pathol; 2012 May; 137(5):753-60. PubMed ID: 22523214
[TBL] [Abstract][Full Text] [Related]
19. Role of p16(INK4a) cytology testing as an adjunct to enhance the diagnostic specificity and accuracy in human papillomavirus-positive women within an organized cervical cancer screening program.
Gustinucci D; Passamonti B; Cesarini E; Butera D; Palmieri EA; Bulletti S; Carlani A; Staiano M; D'Amico MR; D'Angelo V; Di Dato E; Martinelli N; Malaspina M; Spita N; Tintori B; Fulciniti F
Acta Cytol; 2012; 56(5):506-14. PubMed ID: 23075891
[TBL] [Abstract][Full Text] [Related]
20. Quality metrics in cervical cytopathology: A single institutional study.
Senthil Kumar D; Ravikumar G
Cytopathology; 2022 Mar; 33(2):230-235. PubMed ID: 34854153
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
